[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @kaitan000 Kai Tan Kai Tan posts on X about adoption, tan, alltime, insider the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1432515803673350145/interactions)  - X Week XXXXX +98% - X Month XXXXX +7,196% - X Months XXXXX +591% ### Mentions: X [#](/creator/twitter::1432515803673350145/posts_active)  ### Followers: XXX [#](/creator/twitter::1432515803673350145/followers)  - X Week XXX +5.70% - X Month XXX +56% - X Months XXX +52% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1432515803673350145/influencer_rank)  ### Social Influence [#](/creator/twitter::1432515803673350145/influence) --- **Social category influence** [finance](/list/finance) **Social topic influence** [adoption](/topic/adoption), [tan](/topic/tan), [alltime](/topic/alltime), [insider](/topic/insider), [$rely](/topic/$rely), [$dcth](/topic/$dcth) **Top assets mentioned** [Remitly Global, Inc. Common Stock (RELY)](/topic/$rely) ### Top Social Posts [#](/creator/twitter::1432515803673350145/posts) --- Top posts by engagements in the last XX hours "Recent concerns around rising stablecoin adoption the proposed OBBB XXX% tax on remittances and insider selling activity/Naspers sale may be overblown. $RELY is currently trading near its all-time low EV/sales multiple of approximately 2.2x despite projected FY2025 revenue growth of XX% and a potential inflection toward profitability in the coming quarters. Given this setup I believe the risk-reward profile is skewed favorably to the upside"  [@kaitan000](/creator/x/kaitan000) on [X](/post/tweet/1946191229957628119) 2025-07-18 12:52:02 UTC XXX followers, XXX engagements "Why $DCTH may continue to rise in the future. Financial Guidance for 2025: - Revenue: Delcath projects total revenue from HEPZATO KIT and CHEMOSAT to be $94$98 million a 150%+ increase from 2024s $XXXX million driven by U.S. commercial expansion and increased adoption of HEPZATO for metastatic uveal melanoma (mUM). - Gross Margins: Expected to range between XX% and XX% reflecting strong profitability potential. - EBITDA and Cash Flow: Positive adjusted EBITDA and cash flow are anticipated in each quarter of 2025 supported by revenue growth and operational efficiencies. Q1 2025 reported a"  [@kaitan000](/creator/x/kaitan000) on [X](/post/tweet/1940768830462255343) 2025-07-03 13:45:21 UTC XXX followers, 4795 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kai Tan posts on X about adoption, tan, alltime, insider the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance
Social topic influence adoption, tan, alltime, insider, $rely, $dcth
Top assets mentioned Remitly Global, Inc. Common Stock (RELY)
Top posts by engagements in the last XX hours
"Recent concerns around rising stablecoin adoption the proposed OBBB XXX% tax on remittances and insider selling activity/Naspers sale may be overblown. $RELY is currently trading near its all-time low EV/sales multiple of approximately 2.2x despite projected FY2025 revenue growth of XX% and a potential inflection toward profitability in the coming quarters. Given this setup I believe the risk-reward profile is skewed favorably to the upside" @kaitan000 on X 2025-07-18 12:52:02 UTC XXX followers, XXX engagements
"Why $DCTH may continue to rise in the future. Financial Guidance for 2025: - Revenue: Delcath projects total revenue from HEPZATO KIT and CHEMOSAT to be $94$98 million a 150%+ increase from 2024s $XXXX million driven by U.S. commercial expansion and increased adoption of HEPZATO for metastatic uveal melanoma (mUM). - Gross Margins: Expected to range between XX% and XX% reflecting strong profitability potential. - EBITDA and Cash Flow: Positive adjusted EBITDA and cash flow are anticipated in each quarter of 2025 supported by revenue growth and operational efficiencies. Q1 2025 reported a" @kaitan000 on X 2025-07-03 13:45:21 UTC XXX followers, 4795 engagements
/creator/x::kaitan000